ACAD is ACADIA Pharmaceuticals Inc. (Healthcare) — a non-dividend-paying stock. Trading at $28.93. Market cap: $4.98B. Capital Quality Rank: 80/100 — Elite compounder.
Stock snapshot
| Price | $28.93 |
| Market cap | $4.98B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 80 / 100 · Elite compounder |
| ROIC (TTM) | 7.9% |
| Revenue CAGR (3y) | 27.5% |
| Shareholder buyback yield | -2.09% |
| Altman Z-score zone | Safe |
About ACAD
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
Related non-dividend companies
Other non-dividend stocks investors research alongside ACAD. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ACAD's current stock price?
ACAD (ACADIA Pharmaceuticals Inc.) is currently trading at $28.93.
Does ACAD pay a dividend?
ACAD (ACADIA Pharmaceuticals Inc.) does not currently pay a regular dividend.
What is ACAD's Capital Quality Rank?
ACAD has a Capital Quality Rank of 80/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track ACAD in DiviDrip
Add ACAD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ACAD and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.